These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 27485003)
81. Illuminating Host-Mycobacterial Interactions with Genome-wide CRISPR Knockout and CRISPRi Screens. Lai Y; Babunovic GH; Cui L; Dedon PC; Doench JG; Fortune SM; Lu TK Cell Syst; 2020 Sep; 11(3):239-251.e7. PubMed ID: 32970993 [TBL] [Abstract][Full Text] [Related]
82. GEMINI: a variational Bayesian approach to identify genetic interactions from combinatorial CRISPR screens. Zamanighomi M; Jain SS; Ito T; Pal D; Daley TP; Sellers WR Genome Biol; 2019 Jul; 20(1):137. PubMed ID: 31300006 [TBL] [Abstract][Full Text] [Related]
83. Identifying chemogenetic interactions from CRISPR screens with drugZ. Colic M; Wang G; Zimmermann M; Mascall K; McLaughlin M; Bertolet L; Lenoir WF; Moffat J; Angers S; Durocher D; Hart T Genome Med; 2019 Aug; 11(1):52. PubMed ID: 31439014 [TBL] [Abstract][Full Text] [Related]
84. Systematic Comparison of CRISPR and shRNA Screens to Identify Essential Genes Using a Graph-Based Unsupervised Learning Model. Ding Y; Denomy C; Freywald A; Pan Y; Vizeacoumar FJ; Vizeacoumar FS; Wu FX Cells; 2024 Oct; 13(19):. PubMed ID: 39404416 [TBL] [Abstract][Full Text] [Related]
85. Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library. Olivieri M; Durocher D STAR Protoc; 2021 Mar; 2(1):100321. PubMed ID: 33598657 [TBL] [Abstract][Full Text] [Related]
86. mSphere of Influence: Systemic decoding gene function in Wang Y mSphere; 2023 Aug; 8(4):e0027123. PubMed ID: 37382434 [TBL] [Abstract][Full Text] [Related]
87. CancerGD: A Resource for Identifying and Interpreting Genetic Dependencies in Cancer. Bridgett S; Campbell J; Lord CJ; Ryan CJ Cell Syst; 2017 Jul; 5(1):82-86.e3. PubMed ID: 28711281 [TBL] [Abstract][Full Text] [Related]
88. Reproducibility metrics for context-specific CRISPR screens. Billmann M; Ward HN; Aregger M; Costanzo M; Andrews BJ; Boone C; Moffat J; Myers CL Cell Syst; 2023 May; 14(5):418-422.e2. PubMed ID: 37201508 [TBL] [Abstract][Full Text] [Related]
89. Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding. Drost J; Clevers H Mol Cell; 2016 Aug; 63(3):352-4. PubMed ID: 27494556 [TBL] [Abstract][Full Text] [Related]
90. Designing custom CRISPR libraries for hypothesis-driven drug target discovery. Iyer VS; Jiang L; Shen Y; Boddul SV; Panda SK; Kasza Z; Schmierer B; Wermeling F Comput Struct Biotechnol J; 2020; 18():2237-2246. PubMed ID: 32952937 [TBL] [Abstract][Full Text] [Related]
91. Complementary CRISPR genome-wide genetic screens in PARP10-knockout and overexpressing cells identify synthetic interactions for PARP10-mediated cellular survival. Khatib JB; Schleicher EM; Jackson LM; Dhoonmoon A; Moldovan GL; Nicolae CM Oncotarget; 2022; 13():1078-1091. PubMed ID: 36187556 [TBL] [Abstract][Full Text] [Related]
93. Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo. Codina A; Renauer PA; Wang G; Chow RD; Park JJ; Ye H; Zhang K; Dong MB; Gassaway B; Ye L; Errami Y; Shen L; Chang A; Jain D; Herbst RS; Bosenberg M; Rinehart J; Fan R; Chen S Cell Syst; 2019 Feb; 8(2):136-151.e7. PubMed ID: 30797773 [TBL] [Abstract][Full Text] [Related]
94. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras. Wang T; Yu H; Hughes NW; Liu B; Kendirli A; Klein K; Chen WW; Lander ES; Sabatini DM Cell; 2017 Feb; 168(5):890-903.e15. PubMed ID: 28162770 [TBL] [Abstract][Full Text] [Related]
95. The Cancer Dependency Map enables drug mechanism-of-action investigations. Vazquez F; Boehm JS Mol Syst Biol; 2020 Jul; 16(7):e9757. PubMed ID: 32696566 [TBL] [Abstract][Full Text] [Related]
96. Towards a comprehensive catalogue of validated and target-linked human enhancers. Gasperini M; Tome JM; Shendure J Nat Rev Genet; 2020 May; 21(5):292-310. PubMed ID: 31988385 [TBL] [Abstract][Full Text] [Related]
97. Spatial CRISPR genomics identifies regulators of the tumor microenvironment. Dhainaut M; Rose SA; Akturk G; Wroblewska A; Nielsen SR; Park ES; Buckup M; Roudko V; Pia L; Sweeney R; Le Berichel J; Wilk CM; Bektesevic A; Lee BH; Bhardwaj N; Rahman AH; Baccarini A; Gnjatic S; Pe'er D; Merad M; Brown BD Cell; 2022 Mar; 185(7):1223-1239.e20. PubMed ID: 35290801 [TBL] [Abstract][Full Text] [Related]
98. Targeting differentiation blockade in AML: New hope from cell-surface-based CRISPR screens. Su R; Qing Y; Chen J Cell Stem Cell; 2021 Apr; 28(4):585-587. PubMed ID: 33798415 [TBL] [Abstract][Full Text] [Related]
99. Decoding γδ T cell anticancer therapies: integrating CRISPR screens with tumor organoids. Zhou J; Wu M; Yang G Signal Transduct Target Ther; 2023 Nov; 8(1):423. PubMed ID: 37953309 [No Abstract] [Full Text] [Related]